357 related articles for article (PubMed ID: 18406345)
1. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C.
Mori K; Abe K; Dansako H; Ariumi Y; Ikeda M; Kato N
Biochem Biophys Res Commun; 2008 Jun; 371(1):104-9. PubMed ID: 18406345
[TBL] [Abstract][Full Text] [Related]
2. Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA.
Abe K; Ikeda M; Dansako H; Naka K; Kato N
Virus Res; 2007 Apr; 125(1):88-97. PubMed ID: 17239465
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
[TBL] [Abstract][Full Text] [Related]
4. A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replication.
Dansako H; Ikeda M; Abe K; Mori K; Takemoto K; Ariumi Y; Kato N
Virus Res; 2008 Oct; 137(1):72-9. PubMed ID: 18602954
[TBL] [Abstract][Full Text] [Related]
5. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
[TBL] [Abstract][Full Text] [Related]
6. [Replication of hepatitis C virus genome].
Kato N
Uirusu; 2008 Dec; 58(2):191-8. PubMed ID: 19374197
[TBL] [Abstract][Full Text] [Related]
7. Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems.
Cagnon L; Wagaman P; Bartenschlager R; Pietschmann T; Gao T; Kneteman NM; Tyrrell DL; Bahl C; Niven P; Lee S; Simmen KA
J Virol Methods; 2004 Jun; 118(1):23-31. PubMed ID: 15158065
[TBL] [Abstract][Full Text] [Related]
8. [The direct antiviral effect of interferon-gamma on hepatitis C virus replicon].
Jia YT; Wei L; Jiang D; Cong X; Fei R
Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):7-10. PubMed ID: 16420756
[TBL] [Abstract][Full Text] [Related]
9. Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype.
Namba K; Naka K; Dansako H; Nozaki A; Ikeda M; Shiratori Y; Shimotohno K; Kato N
Biochem Biophys Res Commun; 2004 Oct; 323(1):299-309. PubMed ID: 15351737
[TBL] [Abstract][Full Text] [Related]
10. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
Jarczak D; Korf M; Beger C; Manns MP; Krüger M
FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
[TBL] [Abstract][Full Text] [Related]
11. cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cells.
Abe K; Ikeda M; Dansako H; Naka K; Shimotohno K; Kato N
Virus Res; 2005 Jan; 107(1):73-81. PubMed ID: 15567036
[TBL] [Abstract][Full Text] [Related]
12. Replication and infectivity of a novel genotype 1b hepatitis C virus clone.
Date T; Morikawa K; Tanaka Y; Tanaka-Kaneko K; Sata T; Mizokami M; Wakita T
Microbiol Immunol; 2012 May; 56(5):308-17. PubMed ID: 22320232
[TBL] [Abstract][Full Text] [Related]
13. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication.
Ariumi Y; Kuroki M; Abe K; Dansako H; Ikeda M; Wakita T; Kato N
J Virol; 2007 Dec; 81(24):13922-6. PubMed ID: 17855521
[TBL] [Abstract][Full Text] [Related]
14. [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon].
Jia YT; Wei L; Jiang D; Cong X; Fei R
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2065-9. PubMed ID: 16313804
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection.
Sarrazin C; Mihm U; Herrmann E; Welsch C; Albrecht M; Sarrazin U; Traver S; Lengauer T; Zeuzem S
J Infect Dis; 2005 Nov; 192(10):1710-9. PubMed ID: 16235168
[TBL] [Abstract][Full Text] [Related]
16. In vitro replicative properties of replicons constructed using sequence variants of the hepatitis C virus strain AD78 that caused a single-source outbreak of hepatitis C.
Oniangue-Ndza C; Aus dem Siepen M; Lohmann V; Wiese M; Viazov S; Roggendorf M
Virus Res; 2009 Jun; 142(1-2):1-9. PubMed ID: 19103237
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha and ribavirin resistance of Huh7 cells transfected with HCV subgenomic replicon.
Aus dem Siepen M; Oniangue-Ndza C; Wiese M; Ross S; Roggendorf M; Viazov S
Virus Res; 2007 Apr; 125(1):109-13. PubMed ID: 17254660
[TBL] [Abstract][Full Text] [Related]
18. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1.
Taylor DR; Puig M; Darnell ME; Mihalik K; Feinstone SM
J Virol; 2005 May; 79(10):6291-8. PubMed ID: 15858013
[TBL] [Abstract][Full Text] [Related]
19. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
[TBL] [Abstract][Full Text] [Related]
20. In vitro replication models for the hepatitis C virus.
Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ
J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
